[go: up one dir, main page]

CU20090072A7 - Ácido l-glutámico marcado con [f-18], l-glutamina marcada con [f-18], sus derivados y su uso, así como procedimientos para su preparación - Google Patents

Ácido l-glutámico marcado con [f-18], l-glutamina marcada con [f-18], sus derivados y su uso, así como procedimientos para su preparación

Info

Publication number
CU20090072A7
CU20090072A7 CU20090072A CU20090072A CU20090072A7 CU 20090072 A7 CU20090072 A7 CU 20090072A7 CU 20090072 A CU20090072 A CU 20090072A CU 20090072 A CU20090072 A CU 20090072A CU 20090072 A7 CU20090072 A7 CU 20090072A7
Authority
CU
Cuba
Prior art keywords
marked
glutamic acid
derivatives
glutamine
procedures
Prior art date
Application number
CU20090072A
Other languages
English (en)
Other versions
CU23825B1 (es
Inventor
Mathias Berndt
Olga Ferdorovna Kuznetsova
Yuri Belokon
Raisa Nikolaevna Krasikowa
Mathias Friebe
Ludger Dinkelborg
Keith Graham
Lutz Lehmann
Heribert Schmitt-Willich
Original Assignee
Inst Of The Human Brain Ras
Ineos Ras
Bayer Schering Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from RU2006138584/04A external-priority patent/RU2395489C2/ru
Priority claimed from EP06090211A external-priority patent/EP1923382A1/de
Application filed by Inst Of The Human Brain Ras, Ineos Ras, Bayer Schering Pharma Ag filed Critical Inst Of The Human Brain Ras
Publication of CU20090072A7 publication Critical patent/CU20090072A7/es
Publication of CU23825B1 publication Critical patent/CU23825B1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0402—Organic compounds carboxylic acid carriers, fatty acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B59/00—Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
    • C07B59/001—Acyclic or carbocyclic compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C227/00—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C227/14—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from compounds containing already amino and carboxyl groups or derivatives thereof
    • C07C227/16—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from compounds containing already amino and carboxyl groups or derivatives thereof by reactions not involving the amino or carboxyl groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C229/24—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having more than one carboxyl group bound to the carbon skeleton, e.g. aspartic acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C251/00—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton
    • C07C251/02—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton containing imino groups
    • C07C251/24—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton containing imino groups having carbon atoms of imino groups bound to carbon atoms of six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06—Esters of carbamic acids
    • C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C271/22—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by carboxyl groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
    • C07C309/63—Esters of sulfonic acids
    • C07C309/64—Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to acyclic carbon atoms
    • C07C309/65—Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to acyclic carbon atoms of a saturated carbon skeleton
    • C07C309/66—Methanesulfonates
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
    • C07C309/63—Esters of sulfonic acids
    • C07C309/72—Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C309/73—Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton to carbon atoms of non-condensed six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24—Oxygen or sulfur atoms
    • C07D207/26—2-Pyrrolidones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24—Oxygen or sulfur atoms
    • C07D207/26—2-Pyrrolidones
    • C07D207/273—2-Pyrrolidones with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to other ring carbon atoms
    • C07D207/277—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D207/28—2-Pyrrolidone-5- carboxylic acids; Functional derivatives thereof, e.g. esters, nitriles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
    • C07F15/04—Nickel compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
    • C07F15/04—Nickel compounds
    • C07F15/045—Nickel compounds without a metal-carbon linkage
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/05—Isotopically modified compounds, e.g. labelled

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

Se describen los compuestos y la síntesis deácido L- glutámico marcado con (F-18), L-glutamato marcado con (F-18), sus derivados de acuerdo con la fórmula (I) y sus usos.
CU20090072A 2006-11-01 2009-05-04 Ácido l-glutámico y l-glutamina marcados con [f-18] y sus derivados CU23825B1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
RU2006138584/04A RU2395489C2 (ru) 2006-11-01 2006-11-01 [f-18] меченная l-глютаминовая кислота, [f-18] меченный l-глютамин, их производные и их применение, а также способ их получения
EP06090211A EP1923382A1 (de) 2006-11-18 2006-11-18 [F-18] markierte L-Glutaminsäure, [F-18] markiertes Glutamin, ihre Derivate und ihre Verwendung sowie Verfahren zu ihrer Herstellung

Publications (2)

Publication Number Publication Date
CU20090072A7 true CU20090072A7 (es) 2011-09-21
CU23825B1 CU23825B1 (es) 2012-06-21

Family

ID=38896929

Family Applications (1)

Application Number Title Priority Date Filing Date
CU20090072A CU23825B1 (es) 2006-11-01 2009-05-04 Ácido l-glutámico y l-glutamina marcados con [f-18] y sus derivados

Country Status (24)

Country Link
US (2) US20100217011A1 (es)
EP (1) EP2086924B1 (es)
JP (4) JP5529540B2 (es)
KR (1) KR101495924B1 (es)
CN (1) CN101595083B (es)
AR (1) AR071043A1 (es)
AU (1) AU2007315203B2 (es)
BR (1) BRPI0718055A2 (es)
CA (1) CA2667395C (es)
CL (2) CL2007003169A1 (es)
CO (1) CO6180453A2 (es)
CU (1) CU23825B1 (es)
EA (1) EA017713B1 (es)
EC (1) ECSP099304A (es)
ES (1) ES2701423T3 (es)
HK (1) HK1138568A1 (es)
IL (1) IL198022A0 (es)
MX (1) MX2009004686A (es)
NO (1) NO20092123L (es)
NZ (1) NZ576582A (es)
PE (1) PE20091723A1 (es)
SV (1) SV2009003251A (es)
TW (1) TWI415626B (es)
WO (1) WO2008052788A1 (es)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5529540B2 (ja) * 2006-11-01 2014-06-25 ピラマル イメージング ソシエテ アノニム ［ｆ−１８］−ラベルされたｌ−グルタミン酸、［ｆ−１８］−ラベルされたｌ−グルタミン、それらの誘導体、及びそれらの調製のためへのそれらの使用及び方法
EP2123621A1 (de) * 2008-05-20 2009-11-25 Bayer Schering Pharma Aktiengesellschaft Neue {F-18}-markierte L-Glutaminsäure- und L-Glutaminderivate (I), ihre Verwendung sowie Verfahren zu ihrer Herstellung
EP2123619A1 (de) * 2008-05-20 2009-11-25 Bayer Schering Pharma AG Neue [F-18]-Markierte L-Glutaminsäure-und L-Glutaminderivate (II), ihre Verwendung sowie Verfahren zu ihrer Herstellung
EP2123620A1 (en) * 2008-05-20 2009-11-25 Bayer Schering Pharma Aktiengesellschaft {F-19}-labeled L-Glutamic acid and L-Glutamine derivative (III), use thereof and method for obtaining them
EA201100598A1 (ru) 2008-10-10 2011-12-30 Мерк Э Сие F-меченые фолаты в качестве рет радиоактивных индикаторов
US8722014B2 (en) * 2009-05-01 2014-05-13 Washington University 1 H-[1, 2, 3] triazole substituted amino acids and uses thereof
JP2013501813A (ja) * 2009-08-14 2013-01-17 ザ・トラスティーズ・オブ・ザ・ユニバーシティ・オブ・ペンシルバニア ４−フルオログルタミンの単一ジアステレオマーおよびその調製法と利用
KR20120101073A (ko) * 2009-11-17 2012-09-12 바이엘 파마 악티엔게젤샤프트 아이오딘 표지된 호모글루탐산 및 글루탐산 유도체
JP2013510891A (ja) * 2009-11-17 2013-03-28 バイエル・ファルマ・アクチェンゲゼルシャフト Ｆ−１８標識のグルタミン酸誘導体の製造法
EP2322171A3 (en) * 2009-11-17 2011-06-01 Bayer Schering Pharma Aktiengesellschaft Fluorine labeled L-glutamic acid derivatives
EP2338892A1 (en) * 2009-12-18 2011-06-29 Bayer Schering Pharma Aktiengesellschaft Prostate specific membrane antigen inhibitors
WO2012092394A1 (en) 2010-12-29 2012-07-05 Cardinal Health 414, Llc Closed vial fill system for aseptic dispensing
EP2520557A1 (en) 2011-05-03 2012-11-07 Bayer Pharma Aktiengesellschaft Novel precursors of glutamate derivatives
EP2520556A1 (en) 2011-05-03 2012-11-07 Bayer Pharma Aktiengesellschaft Radiolabeled amino acids for diagnostic imaging
US20130020727A1 (en) 2011-07-15 2013-01-24 Cardinal Health 414, Llc. Modular cassette synthesis unit
WO2013012817A1 (en) * 2011-07-15 2013-01-24 Cardinal Health 414, Llc Methods and compositions for drying in the preparation of radiopharmaceuticals
US20130102772A1 (en) 2011-07-15 2013-04-25 Cardinal Health 414, Llc Systems, methods and devices for producing, manufacturing and control of radiopharmaceuticals-full
US9417332B2 (en) 2011-07-15 2016-08-16 Cardinal Health 414, Llc Radiopharmaceutical CZT sensor and apparatus
WO2020010228A1 (en) * 2018-07-06 2020-01-09 The Regents Of The University Of California Deconstructive functionalization methods and compounds
CN109369445B (zh) * 2018-11-20 2021-10-15 首都医科大学 用于诊断和治疗的放射性谷氨酰胺衍生物及其制备方法

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1620522A1 (de) * 1964-12-23 1970-04-23 Takeda Chemical Industries Ltd Verfahren zur Herstellung von 5-substituierten Isoxazolidonverbindungen
FR1461184A (fr) * 1964-12-23 1966-01-07 Takeda Chemical Industries Ltd Procédé de préparation d'isoxazolidones substituées en position 5
US5264570A (en) * 1992-08-05 1993-11-23 General Electric Company Method for making 2-[18 F]fluoro-2-deoxy-D-glucose
US5267570A (en) * 1992-12-30 1993-12-07 Preston Myra S Method of diagnosing and treating chronic fatigue syndrome
GB9324872D0 (en) 1993-12-03 1994-01-19 Univ Pasteur Pharmaceutical compounds
AU779784B2 (en) * 1999-04-01 2005-02-10 Esperion Therapeutics Inc. Ether compounds, compositions, and uses thereof
AU2001278945A1 (en) 2000-08-10 2002-02-25 Eli Lilly And Company 4-substituted d-glutamic acid derivatives for use as antibiotic
EP1314041A2 (en) * 2000-09-01 2003-05-28 Annovis, Inc. Screen for glutamate reuptake inhibitors, stimulators, and modulators
DE10223451A1 (de) * 2002-05-25 2003-12-24 Abx Gmbh Verfahren zur Herstellung von 18F-fluorierten alpha-Aminosäuren
KR20050033067A (ko) * 2002-08-02 2005-04-08 말린크로트, 인코포레이티드 방사성 라벨된 아미노산 유사체, 그 제조방법 및 용도
DE10346228B4 (de) * 2003-09-25 2009-04-09 Eberhard-Karls-Universität Tübingen Universitätsklinikum Herstellung von [18F]fluormarkierten aromatischen L-Aminosäuren
US7270799B2 (en) * 2004-01-15 2007-09-18 Nst Neurosurvival Technologies Ltd. Perturbed membrane-binding compounds and methods of using the same
US7483732B2 (en) 2004-04-15 2009-01-27 Boston Scientific Scimed, Inc. Magnetic resonance imaging of a medical device and proximate body tissue
US20070011016A1 (en) * 2005-07-07 2007-01-11 Alderman Joseph B Springing interests flowing from benefits that run with land
JP5529540B2 (ja) 2006-11-01 2014-06-25 ピラマル イメージング ソシエテ アノニム ［ｆ−１８］−ラベルされたｌ−グルタミン酸、［ｆ−１８］−ラベルされたｌ−グルタミン、それらの誘導体、及びそれらの調製のためへのそれらの使用及び方法
EP2123621A1 (de) 2008-05-20 2009-11-25 Bayer Schering Pharma Aktiengesellschaft Neue {F-18}-markierte L-Glutaminsäure- und L-Glutaminderivate (I), ihre Verwendung sowie Verfahren zu ihrer Herstellung
EP1923382A1 (de) 2006-11-18 2008-05-21 Bayer Schering Pharma Aktiengesellschaft [F-18] markierte L-Glutaminsäure, [F-18] markiertes Glutamin, ihre Derivate und ihre Verwendung sowie Verfahren zu ihrer Herstellung
EP2123620A1 (en) 2008-05-20 2009-11-25 Bayer Schering Pharma Aktiengesellschaft {F-19}-labeled L-Glutamic acid and L-Glutamine derivative (III), use thereof and method for obtaining them
EP2123619A1 (de) * 2008-05-20 2009-11-25 Bayer Schering Pharma AG Neue [F-18]-Markierte L-Glutaminsäure-und L-Glutaminderivate (II), ihre Verwendung sowie Verfahren zu ihrer Herstellung

Also Published As

Publication number Publication date
CL2007003169A1 (es) 2008-07-04
TWI415626B (zh) 2013-11-21
JP2010508317A (ja) 2010-03-18
US20100217011A1 (en) 2010-08-26
PE20091723A1 (es) 2009-12-11
EA017713B1 (ru) 2013-02-28
EP2086924B1 (de) 2018-09-12
ES2701423T3 (es) 2019-02-22
BRPI0718055A2 (pt) 2013-11-05
JP5529540B2 (ja) 2014-06-25
IL198022A0 (en) 2009-12-24
KR20090096597A (ko) 2009-09-11
CN101595083A (zh) 2009-12-02
CL2012000768A1 (es) 2012-09-14
KR101495924B1 (ko) 2015-02-25
JP2014088389A (ja) 2014-05-15
MX2009004686A (es) 2009-09-28
CO6180453A2 (es) 2010-07-19
CA2667395A1 (en) 2008-05-08
JP5815651B2 (ja) 2015-11-17
AR071043A1 (es) 2010-05-26
AU2007315203A1 (en) 2008-05-08
CA2667395C (en) 2016-05-10
ECSP099304A (es) 2009-07-31
JP5749836B2 (ja) 2015-07-15
US20140301948A1 (en) 2014-10-09
HK1138568A1 (en) 2010-08-27
EP2086924A1 (de) 2009-08-12
TW200920407A (en) 2009-05-16
AU2007315203B2 (en) 2013-06-27
WO2008052788A1 (de) 2008-05-08
US9375497B2 (en) 2016-06-28
CU23825B1 (es) 2012-06-21
EA200970428A1 (ru) 2009-12-30
NZ576582A (en) 2011-12-22
NO20092123L (no) 2009-07-30
JP2014062113A (ja) 2014-04-10
SV2009003251A (es) 2009-12-15
JP2014221764A (ja) 2014-11-27
CN101595083B (zh) 2014-12-10

Similar Documents

Publication Publication Date Title
CU20090072A7 (es) Ácido l-glutámico marcado con [f-18], l-glutamina marcada con [f-18], sus derivados y su uso, así como procedimientos para su preparación
CR11800A (es) Nuevos derivados de acido l-glutamico y l-glutamina marcados con [f-18] (i), su uso y procedimiento para su preparacion
ECSP077271A (es) Derivados de pirimidina
ECSP077259A (es) Derivados de pirimidina
CR20110610A (es) Nuevos derivados de pirimidina y sus usos en el tratamiento del cáncer y otras enfermedades
PA8791801A1 (es) Compuestos de pirazol
UY31183A1 (es) Derivados de pirazinona y procesos para su preparación
CO6491116A2 (es) Derivados de 5-fluoropirimidinona
CR11623A (es) Compuestos
DOP2011000171A (es) Compuestos organico
UY31481A1 (es) Nuevos derivados de pirimidina, procesos de preparacion, composiciones farmacéuticas conteniéndolos y aplicaciones
ECSP099565A (es) Compuesto de 2-amino pirimidina
UY31905A (es) Derivados de benzoxazinona, procesos de preparación, composiciones farmacéuticas conteniéndolos y aplicaciones.
ECSP12011651A (es) Derivados de 5-fluoro-2-oxopirimidina-1(2h)-carboxilato
SV2009003429A (es) Derivados de 7-alquinil-1,8-naftiridonas, su preparacion y su aplicacion en terapeutica
ECSP12011653A (es) Derivados de n1-acil-5-fluoropirimidinona
UY32744A (es) Derivados de 2-carboxamida-7-piperazinil-benzofurano 774
UY31836A (es) Nuevo ácido l-glurámico marcado con [f-18] y derivados de l-glutamina marcada con [f-18] (ii), su uso y procedimientos para su preparación
DOP2010000155A (es) Derivados de pirazol como inhibidores de 5-lo
ECSP099679A (es) Nuevos compuestos y sus usos 707
GT200600153A (es) Derivados de tetrahidronaftalina, procedimientos para su preparación y su uso como antiinflamatorios.
SV2007002315A (es) Derivados de octahidropirrolo[3,4-c]pirrol ref. pc32623a
ECSP088933A (es) Métodos para preparar derivados de ácido glutámico y sus intermedios
DOP2009000098A (es) Ácido l-glutamico marcado con [f-18], l-glutamina marcada con [f-18], sus derivados y su uso, así como procedimientos para su preparación
UY30683A1 (es) Acido l-glutamico marcado con [f-18], l-glutamina marcada con [f-18], sus derivados y su uso, asi como procedimientos para su preparacion.

Legal Events

Date Code Title Description
FG Grant of patent
FD Lapse (for not paying fees)